Stay updated with breaking news from Bolt orthopaedics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Share this article DUBLIN, Feb. 1, 2021 /PRNewswire/ X-Bolt Orthopaedics, a leading orthopaedic device company, highlights key results data from the WHITE4 trial, published in February s Bone & Joint Journal, comparing the company s flagship X-Bolt® XHS versus the gold standard Sliding Hip Screw. WHITE4 was the world s largest randomised trial in hip fracture fixation (n=1,128) across ten UK specialist orthopaedic centres. Sliding Hip Screw (SHS) fixation is a well-established treatment of trochanteric hip fractures. XHS differs only by the nature of fixation in the femoral head, using an expanding bolt instead of a lag screw. In WHITE4, patient wellbeing outcome scores at four months were better in more than 90% of XHS versus SHS patients, rising to 95% favouring XHS when crossovers (XHS-allocated who actually received SHS) are excluded and reference is made to baseline pre-injury scores. Reflected into clinical practice, greater than 20% of patients would ....